ABD merkezli ilaç firması Eli Lilly’nin, kanser tedavisi geliştiricisi Scorpion Therapeutics’i 2,5 milyar dolara satın alacağı duyuruldu.
The resource requested could not be found on this server!
Please be advised that LiteSpeed Technologies Inc. is not a web hosting company and, as such, has no control over content found on this site.